Evidence map›Paper›PMID 35407649›Full record

ArticleJournal of clinical medicine2022

Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study.

Izidor Mlakar, Simon Lin, Jama Nateqi, Stefanie Gruarin, Lorena Diéguez, Paulina Piairo, Liliana R Pires, Sara Tement, Ilona Aleksandraviča, Mārcis Leja and 12 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Izidor MlakarFaculty of Electrical Engineering and Computer Science, University of Maribor, 2000 Maribor, Slovenia.ORCID 0000-0002-4910-1879
Simon LinData Science Department, Symptoma, 1030 Vienna, Austria.
Jama NateqiMedical Department, Symptoma, 4864 Attersee, Austria.
Stefanie GruarinMedical Department, Symptoma, 4864 Attersee, Austria.
Lorena DiéguezRUBYnanomed, 4700-314 Braga, Portugal.
Paulina PiairoRUBYnanomed, 4700-314 Braga, Portugal.
Liliana R PiresRUBYnanomed, 4700-314 Braga, Portugal.
Sara TementFaculty of Arts, Department of Psychology, University of Maribor, 2000 Maribor, Slovenia.
Ilona AleksandravičaInstitute of Clinical and Preventive Medicine of the University of Latvia, LV-1586 Riga, Latvia.
Mārcis LejaInstitute of Clinical and Preventive Medicine of the University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-0319-8855
Krista ArcimovičaOncology Centre of Latvia, Riga East Clinical University Hospital, LV-1038 Riga, Latvia.
Valérie BleretDepartment of Senology, University Hospital of Liège, 4000 Liège, Belgium.
Jean-François KauxPhysical and Rehabilitation Medicine, University Hospital of Liège, 4000 Liège, Belgium.
Philippe KolhDepartment of Information Systems Management, University Hospital of Liège, 4000 Liège, Belgium.ORCID 0000-0001-5464-5515
Didier MaquetDepartment of Senology, University Hospital of Liège, 4000 Liège, Belgium.
Jesús Garcia GómezOncology Department, University Hospital Complex of Ourense (SERGAS), 32005 Ourense, Spain.
Jesus García MataOncology Department, University Hospital Complex of Ourense (SERGAS), 32005 Ourense, Spain.
Mercedes SalgadoDepartment of Medical Oncology, Galician Health Services (SERGAS), 15703 Santiago de Compostela, A Coruña, Spain.ORCID 0000-0003-4134-1509
Matej HorvatDepartment of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Maja RavnikDepartment of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Vojko FlisDepartment of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Urška SmrkeFaculty of Electrical Engineering and Computer Science, University of Maribor, 2000 Maribor, Slovenia.ORCID 0000-0003-3516-0429

Funding

European Commission 875406
6 · The paper itself

Abstract

(1) Background: The needs of cancer survivors are often not reflected in practice. One of the main barriers of the use of patient-reported outcomes is associated with data collection and the interpretation of patient-reported outcomes (PROs) due to a multitude of instruments and measuring approaches. The aim of the study was to establish an expert consensus on the relevance and key indicators of quality of life in the clinical practice of breast cancer survivors. (2) Methods: Potential indicators of the quality of life of breast cancer survivors were extracted from the established quality of life models, depicting survivors' perspectives. The specific domains and subdomains of quality of life were evaluated in a two-stage online Delphi process, including an international and multidisciplinary panel of experts. (3) Results: The first round of the Delphi process was completed by 57 and the second by 37 participants. A consensus was reached for the Physical and Psychological domains, and on eleven subdomains of quality of life. The results were further supported by the additional ranking of importance of the subdomains in the second round. (4) Conclusions: The current findings can serve to optimize the use of instruments and address the challenges related to data collection and interpretation as the facilitators of the adaption in routine practice.

Indexed as

breast cancer survivorshipDelphi studyguidancehealth-related quality of life

Identifiers

PMID35407649
PMCPMC8999421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.